Biote projects 2026 revenue above $175M and adjusted EBITDA above $25M as recall-driven disruption delays procedure growth — See source for full details.
$ONCY
Price history, market instrument context, member research, and related headlines in one place.
ONCY key statistics
NasdaqCMUSD
52-week range
$0.4411%$1.32
Latest session $0.442–$0.56Oncolytics Biotech Inc. (ONCY) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $0.538, up $0.05 (9.80%) from the previous close of $0.49. It has traded between $0.442 and $0.56 in the latest session. Over the past year it has ranged from $0.44 to $1.32, leaving it in the lower quarter of its 52-week range (11%). Reported volume for the session was 3.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $ONCY research…